SynthesisJournal of ovarian research2025

A comprehensive comparison of PARP inhibitors as maintenance therapy in platinum-sensitive recurrent ovarian cancer: a systematic review and network meta-analysis.

Shiya Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.